Table 4 Comparison between groups A and B regarding aetiology of liver disease, liver decompensation, complications and drug medication history
Group A | Group B | Test valuea | p-value | Sig | ||||
|---|---|---|---|---|---|---|---|---|
No | % | No | % | |||||
Liver disease | Autoimmune hepatitis | 1 | 8.3% | 5 | 41.7% | 9.333 | 0.230 | NS |
Glycogen storage disease | 3 | 25.0% | 3 | 25.0% | ||||
Chronic hepatitis | 1 | 8.3% | 2 | 16.7% | ||||
HCV | 3 | 25.0% | 0 | 0.0% | ||||
Wilson’s disease | 1 | 8.3% | 2 | 16.7% | ||||
Congenital hepatic fibrosis | 1 | 8.3% | 0 | 0.0% | ||||
Budd Chiari | 1 | 8.3% | 0 | 0.0% | ||||
Niemann Pick | 1 | 8.3% | 0 | 0.0% | ||||
Liver decompensation symptoms | Negative | 9 | 75.0% | 9 | 75.0% | 0.000 | 1.000 | NS |
Positive | 3 | 25.0% | 3 | 25.0% | ||||
Portal hypertension | Negative | 8 | 66.7% | 10 | 83.3% | 0.889 | 0.346 | NS |
Positive | 4 | 33.3% | 2 | 16.7% | ||||
Vitamin D deficiency signs | Negative | 11 | 91.7% | 10 | 83.3% | 0.381 | 0.537 | NS |
Positive | 1 | 8.3% | 2 | 16.7% | ||||
Steroids | 1 | 8.3% | 5 | 41.7% | 3.556 | 0.059 | NS | |
Penicillamine | 1 | 8.3% | 2 | 16.7% | 0.000 | 1.000 | NS | |
Azathioprine | 0 | 0.0% | 2 | 16.7% | 2.182 | 0.140 | NS | |
Inderal | 4 | 33.3% | 2 | 16.7% | 0.889 | 0.346 | NS | |
Marevan | 1 | 8.3% | 0 | 0.0% | 1.043 | 0.307 | NS | |